Article
Effect of CYP3A5 expression on vincristine metabolism with human liver microsomes.
The Journal of pharmacology and experimental therapeutics - 1 May 2007
Dennison Jennifer B, Jones David R, Renbarger Jamie L, Hall Stephen D
Abstract excerpt
Vincristine is preferentially metabolized to a secondary amine, M1, by CYP3A5 with a 9- to 14-fold higher intrinsic clearance than CYP3A4 using cDNA-expressed enzymes. The genetically polymorphic expression of CYP3A5 may contribute to interindividual variability in vincristine efficacy and toxicity. The current study quantifies the contribution of cytochromes P450 (P450s), including CYP3A4 and CYP3A5, to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
